Does short-term estrogen therapy produce lasting benefits in brain?

Endocrinology

Volumn 151, Issue 3, 2010, Pages 843-845

  Gibbs, Robert B ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; CHOLINE ACETYLTRANSFERASE; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GESTAGEN; LIVER PROTEIN;

AGING; ALZHEIMER DISEASE; BRAIN FUNCTION; CANCER RISK; COGNITION; COGNITIVE DEFECT; ESTROGEN THERAPY; HUMAN; MENOPAUSAL SYNDROME; NEUROPROTECTION; PRIORITY JOURNAL; QUALITY OF LIFE; RISK ASSESSMENT; SHORT SURVEY; TREATMENT OUTCOME;

ANIMALS; COGNITION; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; HUMANS;

EID: 77149138335     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2009-1453     Document Type: Short Survey

References (32)

1. Suzuki S, Brown CM, Wise PM 2006 Mechanisms of neuroprotection by estrogen. Endocrine 29:209-215
2. Spencer JL, Waters EM, Romeo RD, Wood GE, Milner TA, McEwen BS 2008 Uncovering the mechanisms of estrogen effects on hippocampal function. Front Neuroendocrinol 29:219-237
3. Daniel JM 2006 Effects of oestrogen on cognition: what have we learned from basic research? J Neuroendocrinol 18:787-795
4. Frick KM 2009 Estrogens and age-related memory decline in rodents: what have we learned and where do we go from here? Horm Behav 55:2-23
5. Gibbs R 2006 Preclinical data relating to estrogen's effects on cognitive performance. In: Rasgon NL, ed. The effects of estrogen on brain function. Baltimore: The Johns Hopkins University Press; 9-45
6. Chen FP 2009 Postmenopausal hormone therapy and risk of breast cancer. Chang Gung Med J 32:140-147
7. Wren BG 2009 The benefits of oestrogen following menopause: why hormone replacement therapy should be offered to postmenopausal women. Med J Aust 190:321-325
8. Lacey Jr JV, Mink PJ, Lubin JH, Sherman ME, Troisi R, Hartge P, Schatzkin A, Schairer C 2002 Menopausal hormone replacement therapy and risk of ovarian cancer. JAMA 288:334-341
9. Miller J, Chan BK, Nelson HD 2002 Postmenopausal estrogen replacement and risk for venous thromboembolism: a systematic review and meta-analysis for the U.S. Preventive Services Task Force. Ann Intern Med 136:680-690
10. Sherwin BB, Henry JF 2008 Brain aging modulates the neuroprotective effects of estrogen on selective aspects of cognition in women: a critical review. Front Neuroendocrinol 29:88-113
11. Shumaker SA, Legault C, Rapp SR, Thal L, Wallace RB, Ockene JK, Hendrix SL, Jones 3rd BN, Assaf AR, Jackson RD, Kotchen JM, Wassertheil-Smoller S, Wactawski-Wende J 2003 Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 289:2651-2662
12. Shumaker SA, Legault C, Kuller L, Rapp SR, Thal L, Lane DS, Fillit H, Stefanick ML, Hendrix SL, Lewis CE, Masaki K, Coker LH 2004 Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA 291:2947-2958
13. Kang JH, Weuve J, Grodstein F 2004 Postmenopausal hormone therapy and risk of cognitive decline in community-dwelling aging women. Neurology 63:101-107
14. Rodgers SP, Bohacek J, Daniel JM 2010 Transient estradiol exposure during middle age in ovariectomized rats exerts lasting effects on cognitive function and the hippocampus. Endocrinology 151:1194-1203
15. Bachmann GA 2005 Menopausal vasomotor symptoms: a review of causes, effects and evidence-based treatment options. J Reprod Med 50:155-165
16. L'hermite M, Simoncini T, Fuller S, Genazzani AR 2008 Could transdermal estradiol + progesterone be a safer postmenopausal HRT? A review. Maturitas 60:185-201
17. Campagnoli C, Ambroggio S, Lotano MR, Peris C 2009 Progestogen use in women approaching the menopause and breast cancer risk. Maturitas 62:338-342
18. Henderson VW 2009 The critical window hypothesis: hormone exposures and cognitive outcomes after menopause. In: Hogervorst E, Henderson V, Gibbs RB, Brinton R, eds. Hormones, cognition and dementia: state of the art and emergent therapeutic strategies. Cambridge, UK: Cambridge University Press; 131-177
19. Zandi PP, Carlson MC, Plassman BL, Welsh-Bohmer KA, Mayer LS, Steffens DC, Breitner JC 2002 Hormone replacement therapy and incidence of Alzheimer disease in older women: the cache county study. JAMA 288:2123-2129
20. Bagger YZ, Tankó LB, Alexandersen P, Qin G, Christiansen C 2005 Early postmenopausal hormone therapy may prevent cognitive impairment later in life. Menopause 12:12-17
21. Sherwin BB 2007 The critical period hypothesis: can it explain discrepancies in the oestrogen-cognition literature? J Neuroendocrinol 19:77-81
22. Maki PM 2006 Hormone therapy and cognitive function: is there a critical period for benefit? Neuroscience 138:1027-1030
23. Mesulam MM 1996 The systems-level organization of cholinergic innervation in the human cerebral cortex and its alterations in Alzheimer's disease. Prog Brain Res 109:285-297
24. Woolf NJ 1991 Cholinergic systems in mammalian brain and spinal cord. Prog Neurobiol 37:475-524
25. Baxter MG, Chiba AA 1999 Cognitive functions of the basal forebrain. Curr Opin Neurobiol 9:178-183
26. Everitt BJ, Robbins TW 1997 Central cholinergic systems and cognition. Annu Rev Psychol 48:649-684
27. von Linstow E, Platt B 1999 Biochemical dysfunction and memory loss: the case of Alzheimer's dementia. Cell Mol Life Sci 55:601-616
28. Smith DE, Roberts J, Gage FH, Tuszynski MH 1999 Age-associated neuronal atrophy occurs in the primate brain and is reversible by growth factor gene therapy. Proc Natl Acad Sci USA 96:10893-10898
29. Lanari A, Amenta F, Silvestrelli G, Tomassoni D, Parnetti L 2006 Neurotransmitter deficits in behavioural and psychological symptoms of Alzheimer's disease. Mech Ageing Dev 127:158-165
30. Gibbs RB 17 December 2009 Estrogen therapy and cognition: a review of the cholinergic hypothesis. Endocr Rev 10.1210/er.2009-0036
31. Woolley CS 2007 Acute effects of estrogen on neuronal physiology. Annu Rev Pharmacol Toxicol 47:657-680
32. Foster TC, Rani A, Kumar A, Cui L, Semple-Rowland SL 2008 Viral vector-mediated delivery of estrogen receptor-α to the hippocampus improves spatial learning in estrogen receptor-α knockout mice. Mol Ther 16:1587-1593